Experimental options in the treatment of heart failure: the role of cytokine antagonism. Article Report uri icon

Overview

MeSH Major

  • Heart Failure
  • Inflammation Mediators
  • Interleukin-6
  • Tumor Necrosis Factor-alpha

abstract

  • Recent studies have identified the importance of biologically active molecules, such as neurohormones, as mediators of disease progression in heart failure. More recently, it has become apparent that, in addition to neurohormones, another portfolio of biologically active molecules, termed cytokines, are also expressed in the setting of heart failure. This article will review recent clinical material that suggests that tumor necrosis factor, a pro-inflammatory cytokine, may contribute to disease progression in heart failure by virtue of the direct toxic effects that this molecule exerts on the heart and circulation. In addition, this article reviews the existing clinical literature, which suggests that cytokine antagonism is safe and potentially effective in patients with heart failure.

publication date

  • January 2001

Research

keywords

  • Report

Identity

PubMed ID

  • 12634895

Additional Document Info

start page

  • 114

end page

  • 21

volume

  • 1

number

  • 4